Literature DB >> 26071904

Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP/NLRP3 inflammasome.

Xiangxiang Wang1, Ruipeng Li1, Xuan Wang1, Qiang Fu1, Shiping Ma2.   

Abstract

Umbelliferone (UMB), a natural antioxidant belonging to coumarin derivatives, is able to cross the blood-brain barrier and protect neuronal cells from death. Here we aimed to investigate the effects of UMB in a rat model of focal cerebral ischemia induced by middle cerebral artery occlusion/reperfusion (MCAO/R). Pretreatment with UMB (15 and 30 mg/kg) for 7 consecutive days ameliorated the neurological outcomes, infarct volume and brain edema in brains of MCAO rats. Our results provided evidence that UMB significantly protected neuronal cells against cerebral ischemia reperfusion-induced injury. Furthermore, UMB treatment could inhibited the level of oxidative stress and the production of inflammatory cytokines in brain tissues of MCAO rats. In addition, UMB significantly upregulated the expression of peroxisome proliferator-activated receptor-γ (PPAR-γ), which exhibited neuroprotective effects in neurodegenerative disease. UMB treatment also suppressed NLRP3 inflammasome activation via reducing expression of Thiredoxin-interactive protein (TXNIP). These results suggest that UMB may have beneficial effects for neuroprotection against focal cerebral ischemic partly through the inhibition of TXNIP/NLRP3 inflammasome and activation of PPAR-γ.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cerebral ischemia–reperfusion; NLRP3 inflammasome; PPAR-γ; TXNIP; Umbelliferone

Mesh:

Substances:

Year:  2015        PMID: 26071904     DOI: 10.1016/j.neulet.2015.06.016

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  36 in total

1.  Inactivation of endothelial adenosine A2A receptors protects mice from cerebral ischaemia-induced brain injury.

Authors:  Yaqi Zhou; Xianqiu Zeng; Ge Li; Qiuhua Yang; Jiean Xu; Min Zhang; Xiaoxiao Mao; Yapeng Cao; Lina Wang; Yiming Xu; Yong Wang; Yu Zhang; Zhengshuang Xu; Chaodong Wu; Jiang-Fan Chen; Md Nasrul Hoda; Zhiping Liu; Mei Hong; Yuqing Huo
Journal:  Br J Pharmacol       Date:  2019-05-21       Impact factor: 8.739

2.  Levo-tetrahydropalmatine Attenuates Neuron Apoptosis Induced by Cerebral Ischemia-Reperfusion Injury: Involvement of c-Abl Activation.

Authors:  Ruoxi Sun; Yichen Song; Shanshan Li; Zhanqiang Ma; Xueyang Deng; Qiang Fu; Rong Qu; Shiping Ma
Journal:  J Mol Neurosci       Date:  2018-07-04       Impact factor: 3.444

Review 3.  The Emerging Role of Thioredoxin-Interacting Protein in Myocardial Ischemia/Reperfusion Injury.

Authors:  Bing F Wang; Jun Yoshioka
Journal:  J Cardiovasc Pharmacol Ther       Date:  2016-11-02       Impact factor: 2.457

Review 4.  Thioredoxin-Interacting Protein (TXNIP) in Cerebrovascular and Neurodegenerative Diseases: Regulation and Implication.

Authors:  Sanaz Nasoohi; Saifudeen Ismael; Tauheed Ishrat
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

Review 5.  Pyroptosis in stroke-new insights into disease mechanisms and therapeutic strategies.

Authors:  Xue Gou; Dan Xu; Fengyang Li; Kai Hou; Weirong Fang; Yunman Li
Journal:  J Physiol Biochem       Date:  2021-05-04       Impact factor: 4.158

Review 6.  Different Roles of Mitochondria in Cell Death and Inflammation: Focusing on Mitochondrial Quality Control in Ischemic Stroke and Reperfusion.

Authors:  Marianna Carinci; Bianca Vezzani; Simone Patergnani; Peter Ludewig; Katrin Lessmann; Tim Magnus; Ilaria Casetta; Maura Pugliatti; Paolo Pinton; Carlotta Giorgi
Journal:  Biomedicines       Date:  2021-02-09

Review 7.  Peroxisome Proliferator-Activated Receptor-Gamma (PPAR-ɣ): Molecular Effects and Its Importance as a Novel Therapeutic Target for Cerebral Ischemic Injury.

Authors:  Ashi Mannan; Nikhil Garg; Thakur Gurjeet Singh; Harmeet Kaur Kang
Journal:  Neurochem Res       Date:  2021-07-20       Impact factor: 3.996

Review 8.  The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets.

Authors:  Rongrong Bai; Yue Lang; Jie Shao; Yu Deng; Reyisha Refuhati; Li Cui
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

Review 9.  Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke.

Authors:  Qingxue Xu; Bo Zhao; Yingze Ye; Yina Li; Yonggang Zhang; Xiaoxing Xiong; Lijuan Gu
Journal:  J Neuroinflammation       Date:  2021-05-31       Impact factor: 8.322

Review 10.  The Role of the Effects of Autophagy on NLRP3 Inflammasome in Inflammatory Nervous System Diseases.

Authors:  Shizhen Zhao; Xiaotian Li; Jie Wang; Honggang Wang
Journal:  Front Cell Dev Biol       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.